FDA-Drug2026-03-11Class IIPROCESSING DEFECT
Teva Metoprolol Succinate Extended-Release 50 mg tablets recalled for failed dissolution
OTHERNationwide distribution
Stop using Teva Metoprolol Succinate 50 mg tablets
Teva Pharmaceuticals is recalling certain batches of Metoprolol Succinate Extended-Release 50 mg tablets because they may not dissolve properly in the body, which could affect how well the medication works. The affected bottles have specific lot numbers and an expiration date of January 2027. No injuries have been reported.
- Check your medication bottle for the lot number and expiration date listed in this recall.
- If your Metoprolol matches the affected lots, contact your pharmacist or doctor for a replacement.
- Do not stop taking your blood pressure medication without talking to your doctor first.
Hazard
Failed Dissolution Specifications
Sold states
Nationwide
Affected count
67,043 bottles
Manufactured in
400 Interpace Pkwy Bldg A, N/A, Parsippany, NJ, United States
Products
Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles (NDC: 45963-676-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0355-2026More Teva Pharmaceuticals USA, Inc recalls
- FDA-Drug2026-04-29Teva Claravis (isotretinoin) 10 mg recalled for elevated tretinoin impurity levels
- FDA-Drug2026-04-15Teva Clonidine Transdermal System 0.2 mg/day recalled for unapproved raw material
- FDA-Drug2026-04-15Teva Clonidine Transdermal System 0.1 mg recalled for unapproved raw material
- FDA-Drug2026-04-15Teva Clonidine Transdermal System 0.3 mg recalled for unapproved raw material
- FDA-Drug2026-04-15Teva Isotretinoin 40 mg capsules recalled for inconsistent strength
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief